相关实验视频
Updated: May 12, 2026

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
15.6K
血清样本中糖尿病相关自身抗体的方法比较
Alexander Lenard1, Andreas Rapp1, Steffen Busch1
1MVZ Labor Dr. Limbach & Kollegen eGbR, Heidelberg, Germany.
Clinical chemistry and laboratory medicine
|August 22, 2025
概括
商业免疫测试平台在检测糖尿病自身抗体方面显示出显著差异. 方法验证显示了结果的不可预测变化,影响了GADA,IA- 2A和ZnT8A的临床诊断和研究准确性.
科学领域:
- 临床化学
- 免疫学
- 糖尿病诊断
背景情况:
- 对胰腺结构元素的自身抗体对于诊断糖尿病至关重要.
- 目前的诊断方法呈现异质性,导致试验之间的可比性存在挑战,并影响临床解释和研究完整性.
研究的目的:
- 验证和比较三种商用平台的性能,用于测量针对谷氨酸脱酶 (GADA),小岛抗原2 (IA-2A) 和输送物8 (ZnT8A) 的自身抗体.
- 评估共识,并确定化学发光免疫测试 (CLIA) 平台与常规酶相关免疫吸收测试 (ELISA) 方法之间的差异.
主要方法:
- 方法验证研究涉及三个平台:欧罗实验室工作站 (ELISA),iFlash 1800 (CLIA) 和Maglumi 800 (CLIA).
- 在平台上测量和比较GADA,IA-2A和ZnT8A自身抗体水平.
主要成果:
- 与常规ELISA相比,Maglumi平台显示了GADA和IA-2A的可接受一致性,而iFlash平台显示的结果不那么有利.
- 对于ZnT8A,iFlash表现出很好的一致性,但Maglumi显著低估了结果,在200U/mL门以下显示了主要的负值.
- 在测试的CLIA器件中,没有在所有三种自身抗体参数上观察到一致的结果.
结论:
- 对于检测GADA和IA-2A,CLIA设备与常规ELISA方法之间存在显著和临床相关的差异.
- 至多有65%的ELISA阳性患者至少有一种CLIA装置的结果是负面的或边缘的,这表明了不可预测的偏差.
- 这些不可预测的偏差无法通过标准校准和内部质量控制程序识别,这突显了糖尿病诊断的关键问题.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

